gallium nitrat advanc paget diseas bone effect dose-respons analysi object brief cours treatment gallium nitrat biochem paramet acceler bone turnov patient advanc paget diseas design unblind trial dose schedul gallium nitrat set univers hospit primari orthoped metabol bone diseas specialti patient patient advanc paget diseas convent therapi consist calcitonin etidron mithramycin intervent patient dose schedul mg/kg bodi weight day continu intraven infus day mg/kg day day subcutan inject mg/kg day day subcutan inject sever patient differ dose schedul patient relaps result fifteen cours treatment patient reduct serum alkalin phosphatas urinari hydroxyprolin excret treatment dose schedul treatment high intermedi low dose median maximum decreas serum alkalin phosphatas activ median maximum decreas urinari hydroxyprolin excret maximum decreas urinari hydroxyprolin excret median week start treatment maximum decreas serum alkalin phosphatas activ median week treatment schedul respons durat variabl rang week conclus short-term treatment gallium nitrat biochem paramet diseas activ patient advanc paget diseas bone larger trial low-dos intermitt treatment schedul safeti effect therapi 